{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T04:37:03Z","timestamp":1794199023194,"version":"4.8.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1095,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Previous studies have shown familial aggregation of insulin resistance and nonalcoholic fatty liver disease (NAFLD). Therefore, we aimed to examine whether family history of diabetes mellitus (DM) is associated with nonalcoholic steatohepatitis (NASH) and fibrosis in patients with NAFLD. This was a cross-sectional analysis in participants of the NAFLD Database study and PIVENS trial who had available data on family history of DM. One thousand and sixty-nine patients (63% women), with mean age of 49.6 (\u00b1 11.8) years and body mass index (BMI) of 34.2 (\u00b1 6.4) kg\/m2, were included. Thirty percent had DM, and 56% had a family history of DM. Both personal history of DM and family history of DM were significantly associated with NASH, with an odds ratio (OR) of 1.93 (95% confidence interval [CI]: 1.37\u20132.73;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt;0.001) and 1.48 (95% CI: 1.11\u20131.97;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.01) and any fibrosis with an OR of 3.31 (95% CI: 2.26\u20134.85;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.001) and 1.66 (95% CI: 1.25\u20132.20;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.001), respectively. When the models were adjusted for age, sex, BMI, ethnicity, and metabolic traits, the association between diabetes and family history of DM with NASH showed an increased adjusted OR of 1.76 (95% CI: 1.13\u20132.72;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.001) and 1.34 (95% CI: 0.99\u20131.81;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.06), respectively, and with any fibrosis with a significant adjusted OR of 2.57 (95% CI: 1.61\u20134.11;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001) and 1.38 (95% CI: 1.02\u20131.87;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.04), respectively. After excluding patients with personal history of diabetes, family history of DM was significantly associated with the presence of NASH and any fibrosis with an adjusted OR of 1.51 (95% CI: 1.01\u20132.25;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.04) and 1.49 (95% CI: 1.01\u20132.20;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.04), respectively.<\/jats:bold>\n                      <jats:bold>Conclusions:<\/jats:bold>\n                      <jats:bold>Diabetes is strongly associated with risk of NASH, fibrosis, and advanced fibrosis. Family history of diabetes, especially among nondiabetics, is associated with NASH and fibrosis in NAFLD.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.25772","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T16:10:34Z","timestamp":1334333434000},"page":"943-951","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":427,"title":["Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis"],"prefix":"10.1097","volume":"56","author":[{"given":"Rohit","family":"Loomba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur","family":"Unalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Lavine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Doo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20250207","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States.","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R2-18-20250207","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R3-18-20250207","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"R4-18-20250207","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.","volume":"45","author":"Angulo","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R5-18-20250207","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory, and histological associations in adults with nonalcoholic fatty liver disease.","volume":"52","author":"NeuschwanderTetri","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R6-18-20250207","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.","volume":"30","author":"Angulo","year":"1999","journal-title":"HEPATOLOGY"},{"issue":"Suppl 1","key":"R9-18-20250207","first-page":"S30S33","article-title":"Genetic influences in nonalcoholic fatty liver disease.","volume":"40","author":"Merriman","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R10-18-20250207","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.","volume":"96","author":"Willner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R11-18-20250207","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.cgh.2006.06.001","article-title":"Familial aggregation of insulin resistance in firstdegree relatives of patients with nonalcoholic fatty liver disease.","volume":"4","author":"Abdelmalek","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-18-20250207","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","article-title":"Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.","volume":"108","author":"Struben","year":"2000","journal-title":"Am J Med"},{"key":"R13-18-20250207","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1900\/RDS.2007.4.236","article-title":"Firstdegree relatives of patients with type 2 diabetes mellitus and risk of nonalcoholic fatty liver disease.","volume":"4","author":"Adibi","year":"2007","journal-title":"Rev Diabet Stud"},{"key":"R15-18-20250207","doi-asserted-by":"crossref","first-page":"872","DOI":"10.7326\/0000605-200912150-00165","article-title":"National Institutes of Health StateoftheScience Conference Statement: Family History and Improving Health.","volume":"151","author":"Berg","year":"2009","journal-title":"Ann Intern Med"},{"key":"R16-18-20250207","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis: PIVENS trial design.","volume":"30","author":"Chalasani","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"R17-18-20250207","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"R19-18-20250207","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R20-18-20250207","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"R21-18-20250207","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R22-18-20250207","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R23-18-20250207","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/oby.2009.4","article-title":"Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.","volume":"17","author":"Wagenknecht","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"R24-18-20250207","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance.","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"R25-18-20250207","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: a followup study of fortytwo patients for up to 21 years.","volume":"11","author":"Powell","year":"1990","journal-title":"HEPATOLOGY"},{"key":"R26-18-20250207","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.","volume":"126","author":"ElSerag","year":"2004","journal-title":"Gastroenterology"},{"key":"R27-18-20250207","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25772","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:51:01Z","timestamp":1738929061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25772","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725357114.793504228","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}